Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Issue of Equity

5 Apr 2016 15:21

RNS Number : 2549U
Impellam Group plc
05 April 2016
 

 

 

IMPELLAM GROUP PLC

("Impellam", the "Group" or the "Company")

Issue of Equity, Director's Shareholding and Total Voting Rights correction

 

Further to the acquisition of Lorien Limited ("Lorien") which completed in November 2014, Impellam announces that it has today issued a total of 719,344 new ordinary shares of 1p each ("Ordinary Shares") to the vendors of Lorien at a price of 831p per share ("Lorien Consideration Shares"). These shares have been issued to part satisfy the final deferred consideration due, now payable of £11.95 million, in accordance with the terms of the earn-out. Subject to satisfactory conclusions of outstanding claims, an additional cash payment of approximately £0.104 million may be payable to the vendors of Lorien.

As part of the deferred consideration payment, Derek O'Neill, a non-executive director of Impellam and major shareholder of Lorien, and his wife, have been issued an aggregate of 261,481 Lorien Consideration Shares and a cash payment, in aggregate, of approximately £1.9 million. Following the issue of Lorien Consideration Shares, Mr O'Neill will have an interest in 707,570 Ordinary Shares representing approximately 1.4 per cent. of the Company's enlarged issued share capital.

In addition, further to the Company's announcements on 8th and 11th December 2015 concerning the acquisition of Bartech Holding Corporation and the related issue of new Ordinary Shares, it has come to the Company's attention that the number of shares issued was incorrectly stated as 401,866 new Ordinary Shares, when it should have stated that 401,668 new Ordinary Shares were issued. Accordingly, the Company's issued share capital with voting rights following the issue of these should have stated 49,623,027 Ordinary Shares, a difference of 198 Ordinary Shares.

Accordingly an application has been made for 719,146 new Ordinary Shares to be admitted to trading on AIM, representing the Lorien Consideration Shares less 198 Ordinary Shares. The Lorien Consideration Shares are expected to be admitted to trading on AIM ("Admission") on 11 April 2015. Following Admission, the Company's issued ordinary share capital will consist of 50,342,371 Ordinary Shares admitted to trading on AIM.

The above figure of 50,342,371 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Enquiries: For further information please contact the appropriate individual below.

Impellam Group plc

Julia Robertson, Chief Executive

Tel: 01582 692658

Darren Mee, Group Finance Director

Tel: 01582 692658

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

 

Nicholas Wells, Mark Connelly

Tel: 020 7397 8900

 

 

 

Impellam Group plc, traded on the AIM (Symbol: IPEL) is a leading provider of managed services and specialist staffing expertise and is primarily based in the UK and North America, with smaller operations in Australasia, Ireland and mainland Europe. Impellam Group plc provides fulfilling jobs to doctors, lawyers, accountants, nurses, teachers, scientists, receptionists, drivers, chefs, administrators, engineers, technology specialists, cleaners, security guards, and manufacturing and warehouse operatives through 18 specialist businesses across a broad range of sectors. Impellam Group plc manage them as teams or individually and help clients build better businesses in a changing world. Impellam Group plc is the 2nd largest recruitment business in the UK, 12th worldwide with over 2,500 Impellam people across over 234 locations worldwide.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESSUFLIFMSEFL
Date   Source Headline
22nd Dec 201710:12 amRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSTransaction in Own Shares
18th Dec 20177:00 amRNSShare Purchase Plan
15th Nov 20173:38 pmRNSTrading Statement
16th Oct 20177:00 amRNSDirectorate Change
2nd Oct 20174:51 pmRNSDirectorate Change
27th Jul 20177:00 amRNSHalf-year Report
28th Jun 201710:49 amRNSResult of AGM
28th Apr 20172:12 pmRNSDirector/PDMR Shareholding
16th Mar 20175:09 pmRNSAnnual Financial Report & Dividend Record Date
9th Mar 20177:00 amRNSPreliminary Results - Unaudited
15th Dec 20167:00 amRNSTrading Update
28th Jul 20167:00 amRNSHalf-year Report
29th Jun 20169:31 amRNSResult of AGM
5th May 20167:00 amRNSQ1 Trading Update
7th Apr 201611:16 amRNSHolding(s) in Company
5th Apr 20163:21 pmRNSIssue of Equity
30th Mar 20162:11 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSDividend Record Date
3rd Mar 20167:00 amRNSPreliminary Results - Unaudited
12th Jan 20168:19 amRNSTrading update and joint broker - replacement
12th Jan 20167:00 amRNSTrading update and appointment of joint broker
14th Dec 201512:15 pmRNSDirector/PDMR Shareholding
11th Dec 20158:01 amRNSTotal Voting Rights
8th Dec 20157:00 amRNSAcquisition and Trading Update
16th Nov 201511:35 amRNSResult of General Meeting
30th Oct 20157:00 amRNSPosting of Circular and Notice of General Meeting
27th Oct 20155:25 pmRNSProposed change in nature of Dividend
2nd Sep 20157:00 amRNSGrant of Options
30th Jul 20157:00 amRNSHalf Yearly Report
13th Jul 20159:00 amRNSPosting of circular
30th Jun 201510:04 amRNSResult of AGM
4th Jun 20157:00 amRNSNotice of AGM and change to dividend timetable
17th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 20154:35 pmRNSIssue of Equity & Director's Shareholding
6th Mar 20159:00 amRNSAnnual Financial Report
3rd Mar 20157:00 amRNSPreliminary Results - Unaudited
16th Jan 20157:00 amRNSPre-Close Trading Update
12th Jan 20157:00 amRNSDirectorate Change
16th Dec 201410:30 amRNSDirectorate Change
13th Nov 20147:30 amRNSHolding(s) in Company
10th Nov 20141:03 pmRNSCompletion of Acquisition and Directorate Change
7th Nov 20147:00 amRNSHolding(s) in Company
4th Nov 20148:00 amRNSDirectors' Dealings
4th Nov 20147:10 amRNSPlacing to raise £15 million
4th Nov 20147:00 amRNSAcquisition of Lorien
30th Jul 20147:00 amRNSHalf Yearly Report
18th Jun 20143:44 pmRNSResult of AGM
15th May 20144:00 pmRNSDeath of a Director
7th May 20147:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.